Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06380452 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Therapy for Scabies With Two Differently Concentrated Permethrin Creams

Study acronym: SKABUP
StatusNot Yet Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The multi-center, prospective, randomized, double-blind phase III clinical trial will primarily investigate the efficacy and safety of treatment of scabies with Permethrin Cream 5% (approved drug InfectoScab 5% Cream) in direct comparison with Permethrin Cream 10%. The trial participants will be randomly assigned and blinded to either Permethrin Cream 5% or Permethrin Cream 10%.
Trial Details
NCT Number NCT06380452
Lead Sponsor Infectopharm Arzneimittel GmbH
Collaborators: Winicker Norimed GmbH
Conditions
(from sponsor)		 Scabies
Related terms Scabies
Enrollment 220 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov